ZHONGCHAO INC-CLASS A (ZCMD)

KYG9897X1152 - Common Stock

1.26  -0.03 (-2.33%)

Fundamental Rating

3

Taking everything into account, ZCMD scores 3 out of 10 in our fundamental rating. ZCMD was compared to 66 industry peers in the Diversified Consumer Services industry. No worries on liquidiy or solvency for ZCMD as it has an excellent financial health rating, but there are worries on the profitability. ZCMD does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

In the past year ZCMD has reported negative net income.
ZCMD had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ZCMD reported negative net income in multiple years.
In multiple years ZCMD reported negative operating cash flow during the last 5 years.

1.2 Ratios

ZCMD has a Return On Assets of -46.43%. This is amonst the worse of the industry: ZCMD underperforms 84.38% of its industry peers.
ZCMD's Return On Equity of -62.95% is on the low side compared to the rest of the industry. ZCMD is outperformed by 71.88% of its industry peers.
Industry RankSector Rank
ROA -46.43%
ROE -62.95%
ROIC N/A
ROA(3y)-17.79%
ROA(5y)-3.55%
ROE(3y)-24.02%
ROE(5y)-6.35%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ZCMD's Gross Margin of 43.80% is in line compared to the rest of the industry. ZCMD outperforms 43.75% of its industry peers.
ZCMD's Gross Margin has declined in the last couple of years.
ZCMD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.77%
GM growth 5Y-7.7%

8

2. Health

2.1 Basic Checks

ZCMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZCMD has been reduced compared to 1 year ago.
ZCMD has less shares outstanding than it did 5 years ago.
ZCMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of 1.19, we must say that ZCMD is in the distress zone and has some risk of bankruptcy.
ZCMD's Altman-Z score of 1.19 is in line compared to the rest of the industry. ZCMD outperforms 56.25% of its industry peers.
There is no outstanding debt for ZCMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.19
ROIC/WACCN/A
WACC7.54%

2.3 Liquidity

ZCMD has a Current Ratio of 6.99. This indicates that ZCMD is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 6.99, ZCMD belongs to the best of the industry, outperforming 95.31% of the companies in the same industry.
ZCMD has a Quick Ratio of 6.77. This indicates that ZCMD is financially healthy and has no problem in meeting its short term obligations.
ZCMD has a Quick ratio of 6.77. This is amongst the best in the industry. ZCMD outperforms 95.31% of its industry peers.
Industry RankSector Rank
Current Ratio 6.99
Quick Ratio 6.77

3

3. Growth

3.1 Past

ZCMD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -284.96%.
The Revenue has grown by 37.33% in the past year. This is a very strong growth!
ZCMD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.60% yearly.
EPS 1Y (TTM)-284.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-117.09%
Revenue 1Y (TTM)37.33%
Revenue growth 3Y2.61%
Revenue growth 5Y8.6%
Sales Q2Q%32.12%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZCMD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ZCMD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZHONGCHAO INC-CLASS A

NASDAQ:ZCMD (11/4/2024, 8:00:02 PM)

1.26

-0.03 (-2.33%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap7.07M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -46.43%
ROE -62.95%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 43.8%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 6.99
Quick Ratio 6.77
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-284.96%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)37.33%
Revenue growth 3Y2.61%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y